Immunotherapy before surgery for advanced melanoma
Part of Cancer, Immune system & allergy clinical trials.
This study looks at how well immunotherapy works before surgery for melanoma that has spread. If you have stage III or IV melanoma that can be removed, you may be able to join this trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have melanoma that has spread to nearby lymph nodes or other parts of the body (stage III or IV).
- Your melanoma can be surgically removed.
- You are being treated with immunotherapy (such as nivolumab, pembrolizumab, or ipilimumab) before surgery.
- You are willing to have the effectiveness of the treatment checked by biopsy or imaging.
- Your melanoma is not uveal melanoma (a rare type of eye melanoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving immunotherapy (anti-PD1) before and after surgery can help treat melanoma that has spread to nearby lymph nodes or skin. It is for people whose melanoma can be removed surgically, and who either haven't had systemic treatment before or whose melanoma has returned after prior immunotherapy or targeted therapy.
This trial tests two immunotherapy drugs, ipilimumab and nivolumab, given before surgery for people whose melanoma has come back after previous anti-PD1 treatment. The goal is to see if this combination can shrink the tumor and help prevent future recurrence.
This trial is for people with stage III melanoma that can be surgically removed. It compares one immunotherapy drug to a combination of two, to see which works better before surgery.
This trial tests immunotherapy given before surgery to help shrink or control stage III melanoma that has spread to nearby areas (lymph nodes/region). If it works, it may improve outcomes after the melanoma is removed.
This trial tests whether giving immunotherapy before surgery and possibly skipping some after may help people with advanced but removable melanoma. It aims to see if this approach can reduce the chance of the cancer coming back.
This trial tests if giving two immunotherapy drugs (nivolumab and ipilimumab) before surgery can improve outcomes for patients with stage III melanoma that can be removed. It is for people who have not had certain treatments recently or whose melanoma is not in the eye.
Hear when a new Melanoma Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.